Recent Finacing
Recent Raise
DelSiTech develops a biodegradable Silica Matrix sol‑gel platform that embeds therapeutics for controlled‑release injectable, implantable and ocular formulations, collaborating with pharma partners and advancing internal drug and vaccine programs.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
